SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue zoomed 8.32% to Rs. 14941.40 millions for the quarter ended September 2023 as compared to Rs. 13793.30 millions during the corresponding quarter last year.Net profit stood at Rs. 3129.40  millions  compared to Rs. 2655.20 millions in the corresponding previous quarter,high by 17.86%.Operating Profit saw a handsome growth to 4363.90 millions from 3768.30 millions in the quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 14941.40 13793.30 8.32 29731.40 26834.50 10.80 53487.30 49133.20 8.86
Other Income 555.10 336.80 64.82 1115.10 602.90 84.96 1541.50 831.60 85.37
PBIDT 4363.90 3768.30 15.81 8473.90 6735.90 25.80 13597.80 11649.30 16.73
Interest 31.30 39.70 -21.16 64.70 81.90 -21.00 159.90 191.00 -16.28
PBDT 4332.60 3728.60 16.20 8409.20 6654.00 26.38 13437.90 11458.30 17.28
Depreciation 178.40 174.70 2.12 350.10 348.20 0.55 699.70 661.00 5.85
PBT 4154.20 3553.90 16.89 8059.10 6305.80 27.80 12738.20 10797.30 17.98
TAX 1024.80 898.70 14.03 2027.30 1594.20 27.17 3244.10 2810.30 15.44
Deferred Tax -18.00 -18.30 -1.64 -35.60 -30.50 16.72 -11.90 -1.30 815.38
PAT 3129.40 2655.20 17.86 6031.80 4711.60 28.02 9494.10 7987.00 18.87
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 29.21 27.32 6.91 28.50 25.10 13.54 25.42 23.71 7.22

Abbott India Share Price

25797.15 -65.00 (-0.25%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×